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Biology of Sexual Dysfunction 
Abstract 
Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the 
endocrine system, the vascular system and a variety of structures that are instrumental in sexual 
excitement, intercourse and satisfaction. Sexual function has three components i.e., desire, arousal and 
orgasm. Many sexual dysfunctions can be categorized according to the phase of sexual response that is 
affected. In actual clinical practice however, sexual desire, arousal and orgasmic difficulties more often 
than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a wide variety 
of psychological and physiological causes including derangements in the levels of sex hormones and 
neurotrensmitters. This review deals with the biology of different phases of sexual function as well as 
implications of hormones and neurotransmitters in sexual dysfunction 
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Abstract:
Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the endocrine system, 
the vascular system and a variety of structures that are instrumental  in sexual  excitement, intercourse and satisfaction. 
Sexual  function  has  three  components  i.e.,  desire,  arousal  and  orgasm.  Many  sexual  dysfunctions  can  be  categorized 
according to the phase of sexual response that is affected. In actual clinical practice however, sexual desire, arousal and 
orgasmic difficulties more often than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a 
wide  variety  of  psychological  and  physiological  causes  including  derangements  in  the  levels  of  sex  hormones  and 
neurotrensmitters.  This review deals  with the biology of  different  phases of  sexual  function as well  as  implications  of 
hormones and neurotransmitters in sexual dysfunction 
Key Words: Sexual dysfunction, Hormones, Neurotransmitters 
Introduction:
Sexual  activity  is  a  multifaceted  activity,  involving 
complex  interactions  between the  nervous  system the 
endocrine system, the vascular system and a variety of 
structures  that  are  instrumental  in  sexual  excitement, 
intercourse  and  satisfaction.(1)  Sexual  function  is  our 
physiological  capacity to experience desire, arousal  and 
orgasm. Normal sexual function requires the integrity of 
the  genitalia,  the  reliable  co-ordination  of  blood  flow, 
the  activation  of  various  smooth  and  skeletal  muscles 
and the stimulation of local secretions. This is linked with 
cognitive processes attending to the sexual meaning of 
what  is  happening.  Problem  anywhere  in  the  entire 
sequence  may  lead  to  sexual  dysfunction.  Sexual 
dysfunction  can  result  from  a  wide  variety  of 
psychological  and  physical  causes.  Pathophysiology  of 
sexual dysfunction involves derangements in the levels of 
sex hormones and neurotransmitters. 
Sexual Response Cycle: 
As defined by Kaplan, this consists of three phases- de-
sire,  arousal  (excitement) and orgasm.(2) However,  the 
division is arbitrary and it only helps to organize clinical 
and  research  oriented  problems  involving  sexuality.  In 
clinical practice sexual desire, arousal and orgasmic diffi-
culties more often than not coexist, suggesting an integ-
ration of phases.
1. Desire (Libido)
It is a complex construct involving physiologic, cognitive, 
behavioural, developmental and cultural components,(3) 
which  are  thought  of  as  the  broad  interest  in  sexual 
experiences  including  thoughts,  fantasies,  dreams  and 
wishes along with an interest in initiating or engaging in 
sexual activity and frustration due to lack of opportunity 
for  sexual  expression.(1)  This  stage  is  hypothetically  a 
dopaminergic  phenomenon  mediated  by  mesolimbic 
dopaminergic "reward centre" including medial preoptic 
area  (MPA)  and  anterior  hypothalamus.  The  reward 
centre  receives  inputs  from  serotonergic  and 
noradrenergic  neurons  and  contains  dopaminergic  cell 
bodies.(4)  Other  contributing  factors  include 
testosterone  and  oxytocin,  as  well  as  personality 
characteristics and psychosocial context.
2.  Arousal
Sexual arousal  is characterized by a subjective sense of 
sexual  excitement  associated  with  observable 
physiological changes such as penile tumescence in men 
and  pelvic  vasocongestion,  vaginal  lubrication  and 
swelling of external genitalia in women. These responses 
may  be  accompanied  in  both  sexes  by  other  bodily 
changes like skin flushing, tachycardia etc.(5)
Psychogenic  penile erections are mediated by impulses 
descending from the cerebral cortex and limbic system 
to  reach  thoracolumbar  sympathetic  ganglia  (inferior 
hypogastric plexus) and sacral parasympathetic ganglion.
(6)  Baseline  non-erect  state  is  maintained  by  tonic 
adrenergic  stimulation  of  µ
1
 and  µ
2
 adrenoceptors.(7) 
The sacral plexus via the pudendal and perineal nerves, 
initiates tactile reflexogenic erections. Hypogastric plexus 
mediates psychogenic penile erections. Efferent impulses 
from  the  parasympathetic  vasodilator  fibers  in  sacral 
plexus  initiate  vasodilatory  mechanism  for  penile 
erection.(8)
Psychological  sexual  arousal  in  women  begins  with 
increased  clitoral  length  and  diameter,  and 
vasocongestion of the vagina, vulva, clitoris, uterus, and 
possibly the urethra.  Pelvic nerve stimulation results  in 
clitoral  smooth  muscle  relaxation  and  arterial  smooth 
muscle dilation. With sexual arousal, there is an increase 
in  clitoral  cavernosal  artery  inflow and  an  increase  in 
clitoral intracavernous pressure that leads to tumescence 
and extrusion of the clitoris. Engorgement of the genital 
vascular  network  increases  pressure  inside  the  vaginal 
capillaries  and  results  in  lubrication  of  the  epithelial 
surface of  the vaginal  wall.  The neurotransmitters  that 
mediate  clitoral  and  arterial  smooth  muscle  dilation 
remain undetermined.(9)
3.  Orgasm
Orgasm in both sexes is characterized by climax of sexual 
pleasure  associated  with  rhythmic  contractions  of 
perineal muscles, cardiovascular and respiratory changes 
and a release of sexual tension.(3)
In men, there are two physiological stages of orgasm – (i) 
Emission, (ii) Ejaculation 
Emission involves the propulsion of seminal fluid to the 
bulbar urethra by the contraction of the smooth muscles 
of the vas deferens, prostate and seminal  vesicles. This 
process  is  thought  to  be  under  the  control  of 
thoracolumbar  sympathetic  nerves  which  release 
norepinephrine  on  to  alpha  receptors.  After  emission, 
the external sphincter is opened to allow release of fluid. 
In  the  second  stage,  a  local,  parasympathetic,  sacral 
spinal  reflex activates  the striated muscles surrounding 
the bulbar urethra, producing ejaculation. The rhythmic 
contraction of these muscles propels the semen outward. 
It is unclear to what degree the occurrence and intensity 
of  orgasm  are  shaped  by  central  neurochemical  and 
cognitive  processes.(5)  Smooth  muscle  controlled 
emission  and  striated  muscle  determined  ejaculation 
involve  separate  nerve  inputs  and  can  be 
pharmacologically distinguished.
In women less is known about the neural mechanisms of 
orgasm and the process is assumed to be largely similar 
to that in the male. Women are capable of experiencing 
multiple orgasms in rapid succession, without the more 
prolonged refractory periods. Mechanisms that make this 
possible are not clear,  although it is hypothesized that 
women are less sensitive to the post-orgasmic secretion 
of prolactin that is hypothesized to produce a refractory 
period in men and women.(10)
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Some  women  ejaculate  fluid  from  the  urethra  with 
orgasm.  Chemical  analysis  of  this  fluid  confirms  that 
while it may be mixed with small amounts of urine, it is 
predominantly a secretion from the paraurethral glands, 
thought to be a vestigial equivalent of the prostate. But 
this  goes unrecognized when it  occurs  in  a retrograde 
direction.(11)
Role of pituitary, adrenal and sex hormones in 
Sexual function: 
Testosterone, estrogen, progesterone, prolactin oxytocin, 
cortisol,  pheromones are the various hormones implic-
ated in sexual function.
Testosterone
Testosterone has been shown to restore nocturnal penile 
tumescence  responses  in  hypogonadal  men,  in  whom 
this is impaired.(12) A recent study showed testosterone 
increased  sexual  arousal  and  enjoyment  among 
hypogonadal and normal men, and had a positive effect 
on  mood  only  among  men  with  abnormally  low 
testosterone  levels.(13)  In  normal  adult  males,  there 
exists  wide  individual  variability  in  circulating 
testosterone levels that do not seem to be linked in any 
meaningful,  way with individual  differences in levels of 
drive or sexual behavior.(14) It is believed that the level 
of testosterone required for sexual interest and activity 
in  adult  males  is  lower than  normal  males’  circulating 
levels  of  testosterone.  Among  males  with  normal 
testosterone levels, testosterone has not been shown to 
facilitate erection.(15)
In  an  earlier  study  of  women  who  had  undergone 
bilateral  oophorectomy and adrenalectomy,  removal of 
the ovaries decreased sexual desire to a certain extent, 
but  removal  of  the  adrenal  glands  had  an  even more 
deleterious  effect  on  desire.(16)  Studies  of  surgically 
menopausal women generally indicate that desire drops 
from  presurgery  level  and  may  be  restored  with 
exogenous administration of supraphysiological levels of 
testosterone with or without estradiol.(17)
Estrogens
Most research suggests that estrogens have little direct 
influence on sexual desire in either males or females. In 
men, relatively high levels of exogenous estrogen have 
been  somewhat  effective  in  inhibiting  sexual  desire 
among  sex  offenders  and  men  who  experience 
uncontrollable  sexual  urges.(18,19)   In  women,  some 
early  studies  have  claimed  that  estrogen  (especially 
estradiol) is important for normal sexual desire, but most 
current  researches  agree  that  estrogens  play  only  a 
minimal role in female sexual desire.(20,21)
Estrogen deficiency, as occurs with menopause, causes a 
decrease  in  genital  vasocongestion,  lubrication  and 
atrophy of the vaginal epithelium. Such changes not only 
impair  the  physiological  sexual  arousal  response  in 
women and may cause dyspareunia (painful intercourse), 
but can adversely influence the psychological experience 
of sexual  arousal.  These changes could be expected to 
indirectly impair sexual desire.(22)
Progesterone
Early studies have revealed a decrease in sexual desire in 
men receiving intramuscular injections of progesterone.
(23,24) No controlled studies have been conducted on 
the  relationship  between  progesterone  treatment  and 
sexual desire in men.
Certain  oral  contraceptives  that  increase  progesterone 
levels  throughout  the  menstrual  cycle  in  female  have 
been  associated  with  decreased  sexual  interest  and 
desire.(25,26)  It  is  generally  agreed on,  however,  that 
progesterone  treatment  does  not  have  a  substantial 
influence on the sexual desire of either premenopausal 
or postmenopausal women.(17,27,28)
Prolactin 
Men and women with abnormally high levels of prolactin 
report a decrease in sexual interest that is restored with 
bromocriptine  treatment.(29)  It  is  unclear  whether the 
reversal of sexual symptoms secondary to bromocriptine 
treatment  is  attributable  to  the  lowering  of  serum 
prolactin  levels,  to  the  correction  of  hypothalamic 
dopaminergic  dysregulation,  or  to  an  interaction 
between these two mechanisms.(30)
Prolactin's  effect  on  other  aspects  of  human  sexual 
behaviour  remains  equivocal.  Erectile  dysfunction  has 
been described in  men with abnormally  high  levels  of 
prolactin, (31) but has also been described in men with 
unusually  low levels  of  prolactin,  (32) suggesting more 
than  a  simple  inhibitory  role  of  prolactin  on  erectile 
ability.  In  women,  abnormally  high  levels  of  prolactin 
have been associated with amenorrhoea,  infertility  and 
decreased sexual ability.(33)
Oxytocin 
Circulating  levels  of  oxytocin  increase  during  sexual 
arousal and orgasm in both men and women.(34) Using a 
continuous  blood  sampling  technique  and 
electromyography,  it  was  reported  to  have  a  positive 
correlation between oxytocin levels and the intensity, but 
not the duration of orgasmic contraction in males and 
females.(35) Most of what we know about the influence 
of  oxytocin  on  sexual  behaviour  however  is  based  on 
animal studies.
Cortisol 
Hypercortisolism  (Cushing  syndrome)  can  produce  a 
constellation  of  symptoms  including  depression, 
insomnia  and  decreased  libido  in  males  and 
females. Cortisol  levels  were  higher  in  men  with 
psychogenic  erectile  dysfunction  who  demonstrated  a 
poor response to intracavernosal injection of a smooth 
muscle relaxant.(36)
Pheromones 
Pheromones are substances secreted from glands at the 
anus,  urinary  outlet,  breasts  and  mouth. In  a  recent 
double blind, placebo-controlled study, it was reported 
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that  women  exposed  to  a  synthesized  human  male 
pheromone reported higher levels of sexual intercourse, 
sleeping  with  a  romantic  partner,  but  no  change  in 
masturbation  frequency.  The authors  interpreted these 
findings as evidence for male pheromones increasing the 
sexual attractiveness of men to women.(37)
Role of neurotransmitters in sexual function
Nitric  oxide,  serotonin,  dopamine,  epinephrine, 
norepinephrine,  acetylcholine,  histamine,  GABA  are  all 
implicated  to  have  roles  in  sexual  function. 
Neurotransmitters  act  both  within  the  brain  and  in 
peripheral organs, and therefore may play complex and 
interacting  roles  in  promoting  and  facilitating  sexual 
functioning.
(a) Nitric oxide (endothelial relaxing factor) 
Nitric  oxide  (NO)  is  an  essential  component  in  the 
production  of  penile,  and  possibly,  clitoral 
vasocongestion and tumescence. The release of NO by 
cholinergic and non-cholinergic nerves appears to be the 
major  contribution  of  the  parasympathetic  nervous 
system.(38) As described above, NO is now understood 
to be the most significant mediator of vascular smooth 
muscle  relaxation,  responsible  for  engorgement  of 
erectile tissue in men and women.
Sexual stimulation leads to NO production that in turn 
stimulates  the  release  of  guanylate  cyclase.  Guanylate 
cyclase  converts  guanosine  triphosphate  to  cGMP and 
cGMP produces relaxation of the smooth muscles of the 
penile  arteries  and  corpus  cavernosum  resulting  in 
increased blood flow into the penis.(39) Some evidence 
suggests that this may also occur in the clitoris.(40)
Normally,  cGMP  is  metabolized  by  cyclic  nucleotide 
phosphodiestrase  isozymes  into  gunanosine  5'- 
monophosphate. As long as sexual stimulation continues, 
cGMP production and metabolism remain balanced and 
penile  or  clitoral  tumescence  is  sustained.(41)  Erectile 
dysfunction can result when this process is not working 
normally or when it is partially or completely disrupted.
(5)
(b) Vasoactive Intestinal Polypeptide (VIP) 
VIP has been less well understood but is shown to co-
localize with NO is nerves to genital  blood vessels and 
smooth muscle. In women, systemic administration and 
local  subepithelial  injection  of  VIP  result  in  increased 
vaginal blood flow and lubrication.(9) In addition, sexual 
arousal  raises the level  of VIP found in the plasma. In 
men VIP also co-localizes with NO and has been shown 
to play an important role in erection.(5)
(c) Serotonin
Serotonin acts at both central and peripheral receptors 
in the mediation of sexual function. (5)
Centrally,  serotonin  appears  to  downregulate  and 
diminish levels of mesolimbic dopaminergic activity and 
to elevate prolactin, resulting in decreased libido.(42,43) 
In addition, serotonergic activation of different receptor 
subtypes  has  differential  effects  on  sexual  functioning. 
Activation  of  receptor  subtype IA lowers  the  thershold 
for ejaculations, while activation of 2A, 1B or IC  
inhibits 
sexual  behaviours  and  stimulation  of  2C facilitates 
behaviour in animal models.(44)
Peripherally, at spinal or end-organ receptors, serotonin 
has inhibitory effects on ejaculation in animals.(45) Also 
serotonin  tends  to  cause  problems  with  orgasm  and 
desire more than arousal itself. Serotonin even acts on 
the smooth muscles of the genitals possibly inhibiting the 
muscular  contractions  that  characterize  orgasm.(5) 
Further,  serotonin  acts  at  peripheral  nerves,  where  it 
appears to affect the flow of genital sensory information. 
Lastly, serotonin may delay orgasm through pre-synaptic 
inhibition of adrenergic transmission.(45)
(d) Dopamine
All  the  four  major  dopaminergic  CNS  pathways  are 
proposed  to  play  a  role  in  sexual  behavior.  The 
incertohypothalamic  pathway  stimulation  increases  all 
phases of male rat sexual behaviour and induces penile 
erection.  In  female  rats  it  induces  sexually  receptive 
posture  called  lardosis.  The  mesolimbic  pathway  is 
involved  in  the  anticipatory  phase  of  sexual  activity 
associated  with  motivation  and  sexual  reward.  The 
nigrostriatal  pathway  is  important  in  the  motor 
behaviour required for consummatory sexual activity in 
male rats. Lastly the tubero infudibular pathway appears 
to play a role in baseline sexual interest as opposed to 
more acute behavioural changes.(5,46,47)
Regarding relationship between dopamine and prolactin, 
it  remains  unclear  whether hyperprolactinemia  itself  is 
causative  or  acts  as  a  surrogate  marker  for  decreased 
dopmine.  A  recent  F-MRI  study  demonstrated  an 
increase  in  blood  flow  to  specific  dopaminergic  and 
other brain structures when 17 college men and women 
viewed  pictures  of  people  they  love  and  are  sexually 
attracted to.(48)
(e) Epinephrine
Plasma  levels  of  epinephrine  have  been  shown  to 
increase prior to viewing an erotic film, slowly increase 
during  masturbation,  peak  at  orgasm,  and  return  to 
baseline level within several minutes of orgasm.(49) The 
epinephrine  and  norepinephrine  metabolite, 
vanillylmandelic acid, increases prior to intercourse and 
continue  to  be  elevated  over  baseline  upto  23  hours 
following sexual activity.(50)
(f) Norepinephrine
In  men,  blood  plasma  NE  levels  were  positively 
correlated with arousal and erection during masturbation 
and sexual activity, increased upto 12-fold at orgasm and 
declined to baseline levels within 2 minutes of reaching 
orgasm.(51,52)  Studies  suggest  that  NE  is  also  active 
during  the  sexual  response  cycle  of  women.  Blood 
plasma  levels  of  NE  increased  during  masturbation, 
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peaked at orgasm, and slowly declined following orgasm 
in normally functioning women.(49,52)
(g) Acetylcholine
Erection occurs when the smooth muscles of the corpus 
cavernosum relax permitting increased blood flow into 
the  penile  tissue.  The  human  corpus  cavernosum  is 
innervated by cholinergic nerves and contains cholinergic 
receptors suggesting endogenous  cholinergic  activity  in 
the penile tissue.(53,54)
Acetylcholine (Ach) appears to play a less direct role in 
sexual  functioning  that  is  largely  a  function  of 
maintaining the balance of cholinergic and sympathetic 
input  at  the  genital  level.(5)  Ach  antagonist,  atropine 
showed no effect  on  either  vaginal  vasocongestion  or 
orgasm in women and large doses were insufficient to 
block  penile  erection  in  men,(9)  though  in  vitro 
administration  of  Ach  to  pre-contracted  corpus 
cavernosum induced smooth muscle relaxation.(7) Thus 
Ach  is  sufficient  to  produce  vasocongestion,  but  not 
essential for this effect.
There  are  three  proposed  roles  for  cholinergic 
stimulation in promoting sexual arousal specifically
• Alteration of the balance of sympathetic and 
parasympathetic inputs.(7) 
• Facilitation of lubrication by increasing secretions.
(55) 
• Synthesis and secretion of NO and VIP, that are 
essential for arousal.(5)
(h) Histamine 
Very  little  is  known  about  the  role  of  histamine  in 
facilitating sexual functioning, but evidence suggests that 
activity  at both H2  and H3 receptors  in the penis  can 
cause  erection.(56)  There  are  a  few  case  reports  of 
decreased  desire  in  both  men  and  women  taking 
cimetidine (H2 antagonist), the mechanism of which may 
be, decreased peripheral response to testosterone (7) or 
decreased  metabolism  of  estradiol  leading  to 
gynaecomastia in men.(57)
(i) Gama aminobutyric acid (GABA)
GABA  enhancing  benzodiazepine  use  has  been 
implicated in case reports  of  decreased libido,  erectile 
dysfunction and anorgasmia.(58) While mechanisms are 
poorly  understood,  it  is  hypothesised  that  centrally 
mediated sedation and peripheral muscle relaxation may 
be responsible.(5)
Apart  from  the  above  mentioned  ones,  many  other 
putative  neurotransmitters,  including  arginine-
vasopressin, angiotensin II, substance P, neuropeptide-Y, 
a-MSH,  Gn  RH are  involved  in  sexual  functioning,  but 
there is little research into their precise role.(59)
Table 1: Stages of sexual response:(60)
Stages of sexual response
Desire
The spontaneous occurrence of sexual thoughts, fantasies, dreams and wishes, along with an 




Genital (vascular engorgement and lubrication) and systemic responses (tachycardia, 
hyperventilation; etc.) to sexual stimulation.
Psychological sense of excitement
Orgasm Intense peak of sexual pleasure accompanied by rhythmic contractions of the genital and 
reproductive organs
Resolution Return to baseline, unaroused state, characterised by loss of vasocongestion in the penis and vulva
Table 2:  Summary of Role of Hormones: (60) 
Stage of sexual response Facilitate sexual function Inhibits sexual function
Desire Testosterone, Oxytocin Prolactin, Cortisol
Arousal Testosterone, Estrogen, Oxytocin -
Orgasm Oxytocin -
Conclusion:
Sexual  function  is  a  complex  phenomenon 
involving  an  orchestra  of  chemical  elements 
ranging from small  molecules like nitric oxide to 
peptides  like  oxytocin.  We  are  aware  that 
derangements  of  various  hormones  and 
neurotransmitters  are  involved  in  sexual 
dysfunction but  their  precise  role  is  not  known. 
Further,  putative  neurotransmitters  are  gaining 
more  implications  in  sexual  dysfunction.  Deeper 
investigation into these areas will no doubt reveal 
greater insight about sexual functioning which in 
turn  assists  in  efficient  management  of  sexual 
dysfunction 
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